P38 MAP kinase inhibitors
US10144721B2 · kind B2 · utility
0Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 6, 2016 |
| Grant date | Dec 4, 2018 |
| Priority date | — |
| Expiry date | Jan 6, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided inter alia a compound of formula (I): wherein R1, J, Ar, L, X, R3 and R4 are as defined in the specification, for use in the treatment of inflammatory disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.